Santen Pharmaceutical Co. Ltd.
SNPHY | OTC
$11.23
+$0.45 (+4.17%)
At close: Oct 30, 2026, 3:15 PM ET
$11.23
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
TTM Period Ending | Q1 2027 Jun 30, 2026 | Q4 2026 Mar 31, 2026 | Q3 2026 Dec 31, 2025 | Q2 2026 Sep 30, 2025 | Q1 2026 Jun 30, 2025 | Q4 2025 Mar 31, 2025 | Q3 2025 Dec 31, 2024 | Q2 2025 Sep 30, 2024 | Q1 2025 Jun 30, 2024 | Q4 2024 Mar 31, 2024 | Q3 2024 Dec 31, 2023 | Q2 2024 Sep 30, 2023 | Q1 2024 Jun 30, 2023 | Q4 2023 Mar 31, 2023 | Q3 2023 Dec 31, 2022 | Q2 2023 Sep 30, 2022 | Q1 2023 Jun 30, 2022 | Q4 2022 Mar 31, 2022 | Q3 2022 Dec 31, 2021 | Q2 2022 Sep 30, 2021 | Q1 2022 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 38.68B | 37.36B | 30.6B | 31.42B | 31.49B | 36.25B | 27.5B | 26.13B | 26.86B | 26.63B | 27.72B | 26.37B | -11.21B | -14.96B | -8.19B | -9.12B | 26.55B | 27.27B | 7.7B | 9.97B | 10.63B |
Depreciation & Amortization | 18.58B | 18.36B | 18.2B | 18.09B | 17.74B | 17.95B | 18.11B | 18.29B | 18.85B | 18.18B | 17.72B | 17.16B | 16.81B | 17.25B | 17.66B | 17.77B | 17.71B | 17.06B | 17.29B | 17.25B | 16.83B |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -2.25B | -988M | -2.25B | -357M | 1.2B | 78M | -1.47B | 6.25B | 4.44B | 1.07B | 970M | -5.31B | -2.48B | -2.56B | -4.97B | -5.33B | -6.45B | -4.06B | -14.71B | -14.49B | -15.11B |
Other Non-Cash Items | -1.12B | 569M | 3.4B | 2.74B | 2.22B | 933M | 5.41B | 9.68B | 13.12B | 12.14B | 15.85B | 11.82B | 38.59B | 41.31B | 31.72B | 30.93B | 1.23B | -131M | 34.49B | 32.73B | 32.89B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -15.1B | -12.79B | -10.78B | -6.06B | 5.06B | 5.8B | 4.23B | 19.13B | 23.42B | 15.7B | 6.82B | -8.8B | -6.92B | -6.46B | 2.15B | -2.3B | 438M | 1.85B | -13.31B | -12.48B | -26.45B |
Operating Cash Flow | 41.04B | 43.5B | 41.41B | 46.19B | 56.51B | 60.93B | 55.25B | 73.23B | 82.24B | 72.65B | 68.11B | 46.55B | 37.27B | 37.15B | 43.34B | 37.28B | 45.92B | 46.04B | 46.17B | 47.48B | 33.9B |
Capital Expenditures | -5.94B | -6.84B | -5.88B | -7.37B | -7.94B | -6.66B | -9.05B | -7.35B | -7.41B | -9.32B | -8.83B | -10.68B | -16.56B | -17.28B | -16.88B | -18.79B | -18.42B | -17.34B | -16.42B | -12.01B | -4.94B |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 59M | 59M | -23.83B |
Purchase of Investments | -212M | -212M | -1.68B | -1.68B | -1.58B | -1.58B | -10M | -369M | -373M | -508M | -503M | -417M | -3.84B | -4.06B | -4.3B | -4.52B | -3.86B | -4.04B | -4.45B | -4.23B | -7.05B |
Sales Maturities Of Investments | 687M | 572M | 3.68B | 4.73B | 4.73B | 4.73B | 4.65B | 3.36B | 3.74B | 4.13B | 1.43B | 1.93B | 2.07B | 2.15B | 4.26B | 4.12B | 3.95B | 3.87B | 1.57B | 3.82B | 3.45B |
Other Investing Acitivies | 1.03B | 932M | -110M | -352M | -372M | -356M | -183M | 103M | 910M | 923M | 916M | 600M | -202M | -279M | 495M | 748M | 747M | 838M | -68M | -45M | -48M |
Investing Cash Flow | -11.68B | -12.97B | -12.59B | -13.32B | -9.4B | -8.22B | -7.66B | -6.84B | -4.46B | -6.15B | -8.91B | -11.75B | -23.25B | -26.78B | -35.53B | -36.92B | -36.51B | -35.17B | -26.28B | -25.68B | -47.67B |
Debt Repayment | n/a | n/a | 1M | 1M | -158M | -158M | -1.95B | -2.06B | -2.11B | -2.11B | -340M | -310M | 4.36B | 4.36B | 14.84B | 14.92B | 20.46B | 20.46B | 7.05B | 7.16B | -2.81B |
Common Stock Repurchased | -25.7B | -32.8B | -32.8B | -41.31B | -33.86B | -37.88B | -37.88B | -29.55B | -22B | -16.96B | -25.06B | -24.78B | -25.85B | -26.01B | -17.91B | -13.01B | -7.2B | n/a | n/a | n/a | n/a |
Dividend Paid | -12.28B | -12.64B | -12.64B | -12.42B | -12.42B | -12.11B | -12.13B | -12.04B | -12.06B | -11.88B | -11.89B | -12.21B | -12.21B | -12.61B | -12.59B | -12.8B | -12.8B | -11.99B | -11.98B | -11.19B | -11.18B |
Other Financial Acitivies | -3.91B | -3.91B | -3.26B | -3.32B | -3.28B | -3.16B | -3.19B | -2.95B | -3.04B | -3.08B | -3.25B | -3.46B | -3.52B | -2.97B | -2.64B | -2.65B | -2.5B | -2.91B | -2.96B | -2.91B | -2.86B |
Financial Cash Flow | -41.89B | -49.35B | -48.7B | -57.04B | -49.71B | -53.31B | -55.16B | -46.6B | -39.21B | -34.03B | -40.55B | -40.76B | -37.21B | -37.22B | -18.29B | -13.54B | -2.04B | 5.56B | -7.88B | -6.94B | -16.85B |
Net Cash Flow | -6.32B | -12.12B | -16.31B | -20.88B | -5.17B | -1.59B | -4.18B | 19.71B | 44.23B | 36.68B | 20.81B | -4.41B | -23.07B | -25.11B | -6.61B | -6.9B | 13.88B | 20.13B | 14.92B | 17.29B | -27.65B |
Free Cash Flow | 35.1B | 36.66B | 35.53B | 38.82B | 48.57B | 54.27B | 46.2B | 65.87B | 74.83B | 63.33B | 59.27B | 35.87B | 20.72B | 19.87B | 26.46B | 18.49B | 27.5B | 28.7B | 29.76B | 35.47B | 28.97B |
Adj. Free Cash Flow | 35.1B | 36.66B | 35.53B | 38.82B | 48.57B | 54.27B | 46.2B | 65.87B | 74.83B | 63.33B | 59.27B | 35.87B | 20.72B | 19.87B | 26.46B | 18.49B | 27.5B | 28.7B | 29.76B | 35.47B | 28.97B |
Maintenance CapEx | -5.15B | -6.05B | -5.88B | -7.37B | -7.94B | -6.19B | -8.57B | -5.75B | -3.96B | -5.08B | -3.1B | -5.43B | -13.15B | -15.04B | -15.72B | -17.65B | -16.9B | -14.77B | -12.98B | -9.22B | -2.27B |
Growth CapEx | -790.29M | -790.29M | n/a | n/a | n/a | -475.49M | -475.49M | -1.61B | -3.45B | -4.24B | -5.73B | -5.25B | -3.4B | -2.23B | -1.15B | -1.15B | -1.52B | -2.58B | -3.44B | -2.79B | -2.67B |
Owner Earnings | 35.89B | 37.45B | 35.53B | 38.82B | 48.57B | 54.74B | 46.68B | 67.48B | 78.28B | 67.57B | 65B | 41.12B | 24.12B | 22.1B | 27.61B | 19.63B | 29.02B | 31.28B | 33.19B | 38.26B | 31.63B |
Add to Watchlist
Select watchlists to add or remove SNPHY